Safety and Efficacy of OC-1 Therapy in Patients With R/R T-ALL/LL
Safety and Efficacy of OC-1 Therapy in Patients With R/R T-ALL/LL
Recruiting · NCT05679895 · Registry updated 2026-03-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of OC-1 Therapy in Patients With R/R T-ALL/LL | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, T-cell acute lymphoblastic leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 | 2026-03-11 | NCT05679895 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Astrum CRO, S.L. | 4 |
| BioClever 2005 S.L. | 3 |
| Hospital Clinic of Barcelona | 95 |
| Hospital Sant Joan de Deu | 15 |
| OneChain Immunotherapeutics | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hospital Clínic | Barcelona | Spain | 2 |
| Hospital Sant Joan de Déu | Barcelona | Spain | 11 |